Topics

Artificial intelligence programs reviewed tens of thousands of human drug studies, found a pattern tied to success, and proposed a lung cancer design later taken up by a manufacturer.

AI-driven drug discovery fueled 26 novel FDA therapy approvals in early 2026, delivering breakthrough cancer treatments and first-ever options for rare neurological disorders.

An AI-designed drug has entered Phase III trials, bringing the pharmaceutical industry closer to its first medicine invented entirely by artificial intelligence.

Researchers have built an artificial intelligence system that predicts long term changes in molecules over ten thousand times faster than usual computer simulations.

A machine learning tool predicts amino acid sequences to create proteins for new vaccines and therapies.

Large language models are changing how new medicines are created in the pharmaceutical industry.